Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

2009256 citationsJournal Articlehybrid Open Access

Authors

Michael Greenbaum · Blackstone (United States)

Lawrence Ginsberg · Houston Eye Associates

William Rory Murphy · Psychiatric Medicine Associates

Abstract

Coadministration of GXR and MPH or AMP was generally safe and associated with statistically significant and clinically meaningful ADHD symptom improvement in children and adolescents.

Topics & Keywords

Attention Deficit Hyperactivity Disorder Children's Physical and Motor Development

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Child and Adolescent Psychopharmacology

Volume 19, Issue 5, pp. 501-510

DOI: 10.1089/cap.2008.0152

Field-Weighted Citation Impact: 5.68